Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | -5.88% | +45.00% | +21.34% |
26/04 | VolitionRx Limited Announces Board Changes | CI |
23/04 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Sales 2024 * | 3.63M 303M | Sales 2025 * | 16.48M 1.37B | Capitalization | 75.02M 6.26B |
---|---|---|---|---|---|
Net income 2024 * | -36M -3B | Net income 2025 * | -32M -2.67B | EV / Sales 2024 * | 18.2 x |
Net cash position 2024 * | 8.9M 742M | Net Debt 2025 * | 18.4M 1.53B | EV / Sales 2025 * | 5.67 x |
P/E ratio 2024 * |
-2.25
x | P/E ratio 2025 * |
-2.83
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.08% |
Latest transcript on VolitionRx Limited
1 day | -5.88% | ||
1 week | +45.00% | ||
Current month | +14.93% | ||
1 month | +12.39% | ||
3 months | -10.31% | ||
6 months | +8.61% | ||
Current year | +21.34% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06/11/06 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 01/21/01 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06/11/06 |
Martin Faulkes
CHM | Chairman | 80 | 06/11/06 |
Guy Innes
BRD | Director/Board Member | 67 | 06/11/06 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 0.87 | -4.78% | 78 364 |
26/24/26 | 0.9137 | +2.65% | 210,159 |
25/24/25 | 0.8902 | +11.27% | 489,819 |
24/24/24 | 0.8 | -5.88% | 354,848 |
23/24/23 | 0.85 | +41.67% | 3,440,054 |
Delayed Quote Nyse, April 30, 2024 at 12:23 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.34% | 75.02M | |
-19.76% | 10.82B | |
+47.29% | 3.25B | |
-32.94% | 2.11B | |
-14.15% | 2.08B | |
-25.79% | 1.48B | |
+19.31% | 1.02B | |
-2.62% | 733M | |
-30.08% | 391M | |
-43.57% | 383M |
- Stock Market
- Equities
- VNRX Stock